Ton Logtenberg

Ton Logtenberg is a founder, President and Chief Executive Officer of Merus N.V., a Nasdaq-listed Immuno-oncology company headquartered in Utrecht, The Netherlands. Ton also co-founded Crucell N.V., serving as its Executive Vice President and Chief Scientific Officer from 2000 until 2003. In 2016, he was appointed professor of Biomedical Entrepreneurship at Utrecht University and serves as a member of the board of directors of the Jenner Foundation, a member of the supervisory board of Utrecht Science Park and a member of the supervisory board of the Foundation Hubrecht Organoid Technology. Prof. Logtenberg holds a Ph.D. in medical biology from Utrecht University.

April 10, 2019 HUB and Yamaha Motor Announce their Collabora... February 1, 2019 – Hubrecht Organoid Technology (HUB) and Yamaha Motor Co., Ltd. (Tokyo:7272) announced today their co... read more
April 09, 2019 Hubrecht Organoid Technology and Crownbio ann... March 27, 2019 – Hubrecht Organoid Technology (HUB) and JSR Corporation, the parent company, of Crown Bioscien... read more